dc.contributorPontificia Universidad Javeriana. Facultad de Medicina. Departamento de Medicina Interna. Neumología
dc.contributorPontificia Universidad Javeriana. Facultad de Medicina. Hospital Universitario San Ignacio
dc.contributorRojas Moreno, Adriana Patricia
dc.contributorCañas Arboleda, Alejandra
dc.contributorJaramillo Garcia, Luis Fernando
dc.creatorRojas Moreno, Adriana Patricia
dc.creatorBrugés Maya, Ricardo Elias
dc.creatorCañas Arboleda, Alejandra
dc.creatorJaramillo García, Luis Fernando
dc.date.accessioned2022-05-31T15:34:10Z
dc.date.accessioned2023-08-29T00:13:35Z
dc.date.available2022-05-31T15:34:10Z
dc.date.available2023-08-29T00:13:35Z
dc.date.created2022-05-31T15:34:10Z
dc.identifier0041-9095
dc.identifierhttp://hdl.handle.net/10554/59932
dc.identifierhttps://doi.org/10.11144/Javeriana.umed57-3.recp
dc.identifierinstname:Pontificia Universidad Javeriana
dc.identifierreponame:Repositorio Institucional - Pontificia Universidad Javeriana
dc.identifierrepourl:https://repository.javeriana.edu.co
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8489563
dc.description.abstractLung cancer is the leading cause of malingnancy death worldwide. This phenomenon occurs when detected in the most advanced stages of the disease (stage III or IV). There are risk factors described in the generation of this cancer such us the consumption o
dc.relation332
dc.relation347
dc.relationUniversitas Medica
dc.relation57
dc.relation3
dc.rightsAtribución-NoComercial 4.0 Internacional
dc.rightshttp://creativecommons.org/licenses/by-nc/4.0/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.subjectEpigenetic Repression
dc.subjectDna Methylation
dc.subjectHistone Code
dc.subjectLung Neoplasms
dc.subjectChromatin
dc.titleEpigenetics regulation of lung cancer : implications for clinical doctor


Este ítem pertenece a la siguiente institución